Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Restart Life Science Logo
Restart Life Science Growth Score
97
CB Rank
30374
Heat Score
82
Restart Life Science is focused on investigating the anti-inflammatory effects of psilocybin in under-explored metabolic indications.
Acquired by
Liberty Leaf Hldgs Logo
Liberty Leaf Hldgs
Founded
obfuscation
PublicPost-IPO Equity Vancouver, British Columbia, Canada1-10 restartlife.co
Biotechnology
Cannabis
Health Care
Therapeutics
Overview

Restart Life Science
Total Funding
obfuscation
Growth Score
97
Heat Score
82

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score97
7 pts
in past quarter
Heat Score 82
15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Restart Life Science

CB Rank
30374
Restart Life Science is focused on investigating the anti-inflammatory effects of psilocybin in under-explored metabolic indications.
Acquired by
Liberty Leaf Hldgs Logo
Liberty Leaf Hldgs
Founded
obfuscation
PublicPost-IPO Equity Vancouver, British Columbia, Canada1-10 restartlife.co
Biotechnology
Cannabis
Health Care
Therapeutics

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Debt
OBF
in
obfuscation

Key People

Details

Legal Name Restart Life Sciences Corp
Also Known As NOVA, Nova Mentis Life Science
Operating Status Active
Stock Symbol  CNSX:HEAL
Company Type For Profit
About the Company
Restart Life Science is a research and development-driven company that is focused on investigating the anti-inflammatory effects of psilocybin in underexplored metabolic indications such as obesity and diabetes.
Predictions & Insights

Growth Insight

See this Growth Insight
Restart Life Science is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Phase IIA Clinical Trial
A clinical study assessing low-dose psilocybin therapy for Fragile X Syndrome using biomarker and AI technology.
Brain Balls™
A functional snack designed to support cognitive performance, focus, and mental clarity.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 6
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Steve Loutskou Logo
Steve Loutskou
—
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
Steve Loutskou Logo
Steve Loutskou
—
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
Steve Loutskou Logo
Steve Loutskou
—
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
Steve Loutskou Logo
Steve Loutskou
—
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—
Steve Loutskou Logo
Steve Loutskou
—
Post-IPO Equity - Restart Life Science Logo
Post-IPO Equity - Restart Life Science
—

Investments

Number of Acquisitions 2

Investment Breakdown

Number of Acquisitions 2

M&A Details

Restart Life Science was acquired by Liberty Leaf Hldgs on
obfuscation
.
Transaction Name 
Restart Life Science acquired by Liberty Leaf Hldgs Logo
Restart Life Science acquired by Liberty Leaf Hldgs
Acquired by 
Liberty Leaf Hldgs Logo
Liberty Leaf Hldgs
Announced Date 
obfuscation
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 3, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

61
-61.39%
 in past month

Active Website Tech Count

9Restart Life Science is actively using 9 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.

Total IP

2Restart Life Science has registered 2 trademarks with the most popular class being 'Basic staples', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Restart Life Science's headquarters? Restart Life Science is located in Vancouver, British Columbia, Canada.Who invested in Restart Life Science? Restart Life Science is funded by Steve Loutskou.When was the last funding round for Restart Life Science? Restart Life Science closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Restart Life Science's competitors? Alternatives and possible competitors to Restart Life Science may include Filament Health, Psyence, and  Nutri-Nation Functional Foods.How much funding has Restart Life Science raised to date? Restart Life Science has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d29fb2e 1)
|